Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Sader

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 29, 2000
Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study GroupA C Gales, R N Jones, M A Pfaller, et al.
Journal of Clinical Microbiology|November 1, 1994
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centersH S Sader, M A Pfaller, F C Tenover, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principlesH S Sader, S M Bhavnani, P G Ambrose, et al.
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramD M Johnson, H S Sader, T R Fritsche, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 4, 2000
Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98)H S Sader, A C Gales, T D Granacher, et al.
Revista Da Associacao Medica Brasileira (1992)|July 1, 1996
[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins]R F Cereda, A C Pignatari, I L Leme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2001
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)A C Gales, R N Jones, K R Forward, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2017
<i>In Vitro</i> Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeaeD J Farrell, H S Sader, P R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Gepotidacin (GSK2140944) <i>In Vitro</i> Activity against Gram-Positive and Gram-Negative BacteriaR K Flamm, D J Farrell, P R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease|February 4, 2018
Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)M A Pfaller, R K Flamm, L R Duncan, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 29, 2000
Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study GroupA C Gales, R N Jones, M A Pfaller, et al.
Journal of Clinical Microbiology|November 1, 1994
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centersH S Sader, M A Pfaller, F C Tenover, et al.
Journal of Chemotherapy (Florence, Italy)|February 21, 2007
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principlesH S Sader, S M Bhavnani, P G Ambrose, et al.
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramD M Johnson, H S Sader, T R Fritsche, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 4, 2000
Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98)H S Sader, A C Gales, T D Granacher, et al.
Revista Da Associacao Medica Brasileira (1992)|July 1, 1996
[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins]R F Cereda, A C Pignatari, I L Leme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2001
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)A C Gales, R N Jones, K R Forward, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2017
<i>In Vitro</i> Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeaeD J Farrell, H S Sader, P R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2017
Gepotidacin (GSK2140944) <i>In Vitro</i> Activity against Gram-Positive and Gram-Negative BacteriaR K Flamm, D J Farrell, P R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease|February 4, 2018
Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)M A Pfaller, R K Flamm, L R Duncan, et al.
Pageof 10